See also this year's filing and all EDGAR filings for this company.
PDF Report 0001716947_2023_Ensysce_Biosciences_Inc.pdf
Logs
Graph
Absolute values for 0001716947, Ensysce Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,299,169 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 585,883 |
| 4 | LiabilitiesCurrent | 9,464,210 |
| 5 | LiabilitiesNoncurrent | 450,494 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,909,603 |
| 9 | ResearchAndDevelopmentExpense | 19,835,875 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,523,383 |
| 12 | remainder_NetIncome | 14,410 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,885,052 |
| 1 | Liabilities | 9,914,704 |
| 2 | Expenses | 26,745,478 |
| 3 | Revenues | 2,523,383 |
| 4 | StockholdersEquity | -4,029,652 |
| 5 | NetIncome | -24,207,685 |
| 6 | ComprehensiveNetIncome | -24,207,685 |
| 7 | BaseVar | 22,541,514 |
| 8 | EconomicCapitalRatio | -3.94 |
Edgar->Model Mapping
Feature Distribution
Change over Time
